- Last sale
- Nov 12, 2026 · -0.30%
- Market cap
- $3.15B
- 49.13M shares
- Filings
- 544
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+636.0% FY25 yoy
- $3.15B
- —
- —
- —
- -4.87%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $144,995,000 | reported | |
| FY 2024 | 2024-12-31 | $104,203,000 | reported | |
| FY 2023 | 2023-12-31 | $60,594,005 | reported | |
| FY 2022 | 2022-12-31 | $35,289,548 | reported | |
| FY 2021 | 2021-12-31 | $25,758,006 | reported | |
| FY 2020 | 2020-12-31 | $7,683,522 | reported | |
| FY 2019 | 2019-12-31 | $6,269,308 | reported | |
| FY 2018 | 2018-12-31 | $6,325,995 | reported | |
| FY 2017 | 2017-12-31 | $4,980,427 | reported | |
| FY 2016 | 2016-12-31 | $3,064,762 | reported |
Medical laboratories
Celcuity Inc. is the 10th largest of the 29 covered companies the SEC files under this code, by market cap. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
CAICaris Life Sciences, Inc.$812.0M97.0%8.4%$6.9BRDNTRadNet, Inc.$2.0B11.5%0.9%$6.0BGRALGrail, Inc.$147.2M17.2%277.5%$5.5BBLLNBillionToOne, Inc.$305.1M100.0%2.4%$5.3BCDNACareDx, Inc.$379.8M13.8%5.6%$4.4B
CELCCelcuity Inc. (this company)———$3.2B
VCYTVeracyte, Inc.$517.1M16.0%12.8%$2.0BFTREFortrea Holdings Inc.$2.7B1.0%36.2%$1.9BPSNLPersonalis, Inc.$69.6M17.7%116.7%$1.7BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Celcuity Inc. · CIK 1603454 · Engraved from SEC EDGAR